Shareholders Approve 300,000 Share Increase for Incentive Plan

summarizeSummary

MediWound Ltd. shareholders approved an increase of 300,000 ordinary shares for its 2024 Share Incentive Plan, representing a potential dilution of approximately 2.34%.

check_boxKey Events

• Share Incentive Plan Expanded

  Shareholders approved an increase of 300,000 ordinary shares for the 2024 Share Incentive Plan.

• Potential Dilution

  The approved increase represents a potential dilution of approximately 2.34% of current outstanding shares.

• Follows Prior Announcement

  This vote finalizes the proposal announced in the 6-K filing on January 15, 2026.

auto_awesomeAnalysis

This filing reports the successful shareholder vote to expand the company's 2024 Share Incentive Plan by 300,000 ordinary shares. This approval, following the extraordinary general meeting announced on January 15, 2026, provides MediWound with additional equity to compensate and incentivize employees and directors. While such plans are crucial for talent retention, the increase represents a potential future dilution of approximately 2.34% for existing shareholders. Investors should monitor the rate at which these shares are granted and their impact on outstanding share count.